Xueying Zhang

发表

[XRCC1 and XPD genetic polymorphisms predict clinical responses to platinum-based chemotherapy in advanced non-small cell lung cancer].

W. Tan, X. Miao, Bing-he Xu, 2006, Zhonghua zhong liu za zhi [Chinese journal of oncology].

Multi-omics integrated circulating cell-free DNA genomic signatures enhanced the diagnostic performance of early-stage lung cancer and postoperative minimal residual disease.

Wenjie Liu, N. Kanu, Jun Wang, 2023, EBioMedicine.